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Abstract
OBJECTIVES: In patients with lung cancer, endosonography has emerged as a minimally invasive method to obtain cytological proof of
mediastinal lymph nodes, suspicious for metastases on imaging. In case of a negative result, it is currently recommended that a cervical
mediastinoscopy be performed additionally. However, in daily practice, a second procedure is often regarded superﬂuous. The goal of our
study was to assess the additional value of a cervical mediastinoscopy, after a negative result of endosonography, in routine clinical
practice.
METHODS: In a retrospective cohort study, the records of 147 consecutive patients with an indication for mediastinal lymph node staging
and a negative result of endosonography were analysed. As a subsequent procedure, 124 patients underwent a cervical mediastinoscopy
and 23 patients were scheduled for an intended curative resection directly. The negative predictive value (NPV) for both diagnostic proce-
dures was determined, as well as the number of patients who needed to undergo a mediastinoscopy to ﬁnd one false-negative result
of endosonography (number needed to treat (NNT)). Clinical data of patients with a false-negative endosonography were analysed.
RESULTS: When using cervical mediastinoscopy as the gold standard, the NPV for endosonography was 88.7%, resulting in a NNT of 8.8
patients. For patients with ﬂuoro-2-deoxyglucose positron emission tomography positive mediastinal lymph nodes, the NNT was 6.1.
Overall, a futile thoracotomy could be prevented in 50% of patients by an additional mediastinoscopy. A representative lymph node
aspirate, containing adequate numbers of lymphocytes, did not exclude metastases.
CONCLUSIONS: In patients with a high probability of mediastinal metastases, based on imaging, and negative endosonography, cervical
mediastinoscopy should not be omitted, not even when the aspirate seems representative.
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INTRODUCTION
In patients with lung cancer, precise clinical staging is mandatory
to provide appropriate therapy. In the absence of distant metasta-
ses, mediastinal lymph node staging is essential to select patients
for an intended curative treatment. Assessment of the mediasti-
num is primarily based on a combination of computed tomog-
raphy (CT) scan and 18ﬂuoro-2-deoxyglucose positron emission
tomography (18FDG-PET). However, despite an improved accuracy
of these imaging modalities over the last decade [1], invasive
staging remains necessary in case of mediastinal lymph node en-
largement, PET positive mediastinal and/or hilar lymph nodes
and/or a centrally located tumour [2, 3]. For a long time, cervical
mediastinoscopy has been considered the gold standard in medi-
astinal staging, given the high negative predictive value (NPV)
if well performed [4]. During the last decade, oesophageal
ultrasound-guided ﬁne needle aspiration (EUS-FNA) followed by
endobronchial ultrasound-guided transbronchial needle aspir-
ation (EBUS-TBNA) has emerged as a minimally invasive alterna-
tive, reducing the need for a cervical mediastinoscopy as a
ﬁrst-line staging procedure. Especially by combining both techni-
ques, nearly all mediastinal lymph node stations are accessible,
thus making it possible to perform cytological analysis of medias-
tinal lymph nodes considered suspicious on imaging. When,
nevertheless, the result of endoscopic staging appears negative,
a subsequent mediastinoscopy is currently recommended to
exclude mediastinal lymph node metastases in patients with clin-
ical suspicion [2]. But, since the sensitivity of EBUS-FNA seems
to exceed that of mediastinoscopy [5, 6], the need for surgical
conﬁrmation may be diminished. Accordingly, in daily practice
an additional mediastinoscopy is often regarded as overdone.
However, recently only the combination of endosonography fol-
lowed by mediastinoscopy was shown to be more accurate in
mediastinal nodal staging than mediastinoscopy alone, reducing
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the rate of futile thoracotomies by more than half. Yet, 11 patients
had to undergo a cervical mediastinoscopy to ﬁnd one positive
result after negative endosonography [7].
The goal of our study was to assess the additional value of a
cervical mediastinoscopy in patients with suspected or proven
non-small-cell lung cancer, after a negative result of endosono-
graphic mediastinal staging, in routine clinical practice.
MATERIALS ANDMETHODS
In a retrospective cohort study, medical records of 147 consecu-
tive patients with suspected or proven non-small-cell lung cancer
and a negative result of combined endosonographic mediastinal
staging between January 2009 and August 2012 were analysed.
All patients were clinically staged based on a diagnostic CT scan
of the chest and upper abdomen, followed by an integrated PET/
CT scan, according to the current Dutch guidelines.
When there was no sign of distant metastasis, endoscopic medi-
astinal lymph node staging was performed in case of enlarged
and/or FDG-PET positive hilar and/or mediastinal lymph nodes,
and/or a centrally located tumour. Lymph nodes with a short axis
>1 cm were considered enlarged, and a tumour was considered
central if located in the inner 1/3 of the lung parenchyma on a
transverse image on CT scan. Since patients were referred from
different hospitals, lymph nodes were considered FDG-PET posi-
tive, when clearly stated in the report of nuclear medicine of the
referring hospital. In case of only a mild increased uptake by hilar
and/or mediastinal lymph nodes and thus a dubious suspicion,
FDG-PET was considered negative.
Endosonographic mediastinal staging, with the availability of
both EUS-FNA and EBUS-TBNA, using Pentax EG3870UTK and
EB1970UK scopes (Pentax Medical, Hamburg, Germany/Tokyo,
Japan) in combination with a Hitachi EUB 7000HV ultrasound
scanner (Hitachi Medical Corp., Japan), was performed as an
outdoor clinic procedure under conscious sedation. All procedures
were performed by two experienced pulmonologists. The choice
for one or both modalities was made by the performing pulmonol-
ogist, based on the location and side of the primary tumour, as well
as the location of the suspicious mediastinal lymph nodes. Although
sometimes aspirated, lymph nodes <5 mmwere regarded as unsuit-
able for assessment. In all patients, FNA was performed using 22G
needles (Medi-Globe and Cook). Rapid on site evaluation (rose) was
available in all cases to assess the yield of the procedure and was
performed by an analyst of the department of pathology. The de-
ﬁnitive diagnosis was based on cytological and immunocytochem-
ical analysis of the obtained slides and cell-block specimens.
After a negative result of endosonography with regard to the
mediastinal lymph nodes, 124 patients were scheduled for a cer-
vical mediastinoscopy and 23 patients directly underwent an
intended curative resection. In these patients, mediastinoscopy
was omitted due to patient factors (laryngectomy, previous cer-
vical radiotherapy and struma).
A cervical mediastinoscopy was performed using a video-
mediastinoscope (Karl Storz GmbH, Tuttlingen, Germany) in all
patients. Performance was based on the recommendations of the
European Society of Thoracic Surgeons (ESTS) [2], with multiple bi-
opsies taken of at least the lower paratracheal lymph nodes on
both sides, as well as the subcarinal lymph nodes, regardless of
their size.
In case of a thoracotomy, a complete resection was performed
according to the deﬁnition of the International Union Against
Cancer (UICC), including a lymph node dissection of at least three
mediastinal stations, always including the subcarinal station [8].
The NPV of endosonography was calculated, using cervical
mediastinoscopy as the gold standard, as well as using the combin-
ation of cervical mediastinoscopy and, when performed, thoracot-
omy as the gold standard. The NPV of mediastinoscopy was
calculated using thoracotomy as the gold standard. Furthermore,
the number of patients who had to undergo a subsequent mediasti-
noscopy to detect one false-negative result of endosonography
(number needed to treat (NNT)) was determined. The analysis was
based on an intention to treat.
Finally, clinical data of patients with a false-negative result of
endosonography were analysed. Statistical analyses were performed
using the SPSS 18.0 statistical software (SPSS, Inc., Chicago, IL, USA).
RESULTS
Imaging
Of all the 147 patients included in this study with an indication for
invasive mediastinal staging, the tumour was located centrally in
52 patients (35%). In 80 patients (54%), lymph nodes in at least
one station appeared to be enlarged on CT scan and FDG-PET
demonstrated positive lymph nodes in 96 patients (65%): hilar
lymph nodes only in 38 patients, mediastinal lymph nodes only in
21 patients and both in 37 patients.
Endosonography
As a result of these ﬁndings on imaging studies, patients were
scheduled for endoscopic mediastinal staging. An EBUS-TBNAwas
performed in 88 patients (60%), an EUS-FNA in 29 patients (20%)
and both modalities were used in 30 patients (20%).
In 147 patients, a total of 259 lymph nodes were aspirated
(mean of 1.8, range 0–5). In 124 patients, both mediastinal and
hilar lymph nodes were examined, with a mean of 1.5 (range 1–4)
mediastinal lymph nodes aspirated. In 5 patients, only hilar lymph
nodes were aspirated. In the remaining 18 patients, no aspiration
was performed.
In addition to the aspirated lymph nodes, 231 lymph nodes in
147 patients (mean 1.6, range 0–4) were inspected. The size of the
aspirated lymph nodes, mean 8.6 mm (range 2–23), was different
from that of the inspected ones, with a mean size of 5.2 mm
(range 1.8–40) (P < 0.001). When aspirated, on average 2.5
samples (range 1–6) per lymph node were taken. In 109 of 124
patients, the yield of at least one mediastinal lymph node was con-
sidered representative by pathology, based on the relative amount
of lymphocytes present in at least one aspirate.
Cervical mediastinoscopy
As a next-step procedure, 124 patients underwent a cervical med-
iastinoscopy, while in 23 patients a thoracotomy was performed
directly (Fig. 1).
Assessment of the mediastinum by mediastinoscopy was in
accordance with the recommendations of the ESTS in 98.5% of
patients. The mean number of mediastinal lymph node stations
biopsied was 4.0 (range 1–5, standard deviation 0.69). In 77
patients 4 stations were biopsied, in 26 patients 5 stations, in 19
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patients 3 stations, in 1 patient 2 stations and in the remaining
patient 1 station.
Mediastinoscopy demonstrated positive lymph nodes in 14 of
124 patients (11%), revealing positive ipsilateral (N2) nodes in 11
patients and positive contralateral (N3) nodes in 3 patients (Table 1).
Of 4 patients with only positive intrapulmonary lymph nodes found
by endosonography, mediastinoscopy was positive in 1.
Thoracotomy
In 100 of the remaining 110 patients, an intended curative resec-
tion was performed, including a mediastinal lymph node dissection
of at least three mediastinal stations. Ten patients did not undergo a
resection: in 6 patients because of poor condition or patient prefer-
ence for a different therapy, in 2 patients because of an irresect-
able tumour and in the last 2 patients the suspected tumour was
proved to be a benign lesion. Despite endosonography followed
by cervical mediastinoscopy, unexpected mediastinal lymph node
metastases were found in 10 of 100 patients (10%) who had
undergone a resection.
In 23 patients, mediastinoscopy was not performed. In 4 of
these patients, mediastinal lymph node metastases were detected
by thoracotomy.
Predictive value
Using only the result of cervical mediastinoscopy as the gold
standard, the NPV for endosonography was 88.7%. When using
both cervical mediastinoscopy and/or thoracotomy as the gold
standard, this NPV was 80.9%.
For a cervical mediastinoscopy, with a thoracotomy as the gold
standard, the NPV was 90%, although the sensitivity was only 58%
in this cohort with a prevalence of N2 disease of 21%.
Since mediastinoscopy was positive in 14 of 124 patients, the
NNT was 8.8 patients.
When only patients with a high probability of mediastinal me-
tastases were considered, based on FDG-PET positive mediastinal
lymph nodes in contrast to only hilar suspicion or a central
tumour, mediastinoscopy was positive in 9 of 55 patients, resulting
in a NNT of 6.1 patients (Table 2).
By adding cervical mediastinoscopy to the clinical workup, in
this series a futile thoracotomy could be prevented in 14 of 28
patients (50%).
Analysis of false-negative endosonography
In 28 patients, the result of mediastinal staging by endosonogra-
phy was false-negative. Of these patients, mediastinal lymph
nodes were enlarged on CT scan in 15 patients and 21 patients
demonstrated positive lymph nodes on FDG-PET (mediastinal
lymph nodes in 12 patients and hilar nodes only in 9 patients).
Five patients had to undergo invasive mediastinal staging because
of a centrally located tumour.
In 4 patients, no lymph nodes were aspirated during endosono-
graphy. In the remaining 24 patients, 39 mediastinal stations were
investigated (average 1.6, range 1–3), in combination with 9 intra-
pulmonary lymph node stations. After cytopathological analysis,
the yield of endosonography was considered representative (i.e.
containing mature as well as immature lymphocytes), in 25 of 39
investigated mediastinal lymph node stations. In 18 of 24 patients
Figure 1: Flow chart of patients with suspected locally advanced lung cancer, after tumour negative mediastinal endosonography, n = 147 patients.
Table 1: Upstaging based on lymph node involvement,
n = 147 patients
After
endosonography
(n = 147 patients)
After cervical
mediastinoscopy





N0/N1 147 110 109
N2 – 11 14
N3 – 3 –
aTwenty-three patients did not undergo a cervical mediastinoscopy.
bTwenty-four patients did not undergo a thoracotomy (14 patients
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the yield of at least one mediastinal station was considered repre-
sentative.
In 14 of 28 patients, the false-negative result of endosonogra-
phy was identiﬁed by mediastinoscopy. In these patients, the
mean number of mediastinal lymph node stations aspirated by
endosonography was 1.5 (range 0–3), compared with 3.9 (range
1–5) biopsied by mediastinoscopy. The lower paratracheal lymph
nodes (Station 4) were responsible for most of the failures of
endosonography, followed by the subcarinal lymph nodes
(Station 7) and upper paratracheal lymph nodes (Station 2)
(Table 3). In 2 patients 2 mediastinal stations were positive by
mediastinoscopy and 3 stations in another 2 patients.
In 7 of these 14 patients, metastases were found in lymph node
stations despite assessment by endosonography, and in only 1 of
them the yield was considered not representative by the patholo-
gist. In 5 patients, metastases appeared in lymph node stations not
examined by endosonography; in the remaining 2 patients, no
lymph nodes had been aspirated (Table 4).
In the remaining 14 of 28 patients unexpected N2 disease was
found by thoracotomy: in 10 patients after negative results of both
endosonography and cervical mediastinoscopy and in 4 patients
after negative endosonography only. Also in this group of patients,
endosonography failed most frequently in the lower paratracheal
lymph nodes (Station 4), followed by the subaortic lymph nodes
(Station 5) and subcarinal lymph nodes (Station 7) (Table 3). In 2
patients, no lymph node aspirates were taken during endosono-
graphy; in 6 patients, metastases were found in lymph node sta-
tions also aspirated by endosonography, with a representative
yield in 3 of them. In the remaining 6 patients, metastases were
found by thoracotomy in lymph node stations not aspirated
during endosonography (Table 4).
In 10 of these 14 patients also mediastinoscopy was false-
negative. In 3 patients, because of positive subaortic and in 1 patient
because of a positive paraoesophageal lymph node, both being out
of reach for a cervical approach. In 6 patients, lymph node stations
were positive despite a biopsy at the time of mediastinoscopy.
DISCUSSION
Treatment planning in patients with a non-small-cell lung carcin-
oma depends on strict and reliable staging. Especially the medias-
tinal lymph nodes are crucial in determining the contribution and
sequence of treatment modalities. For this, EUS- and EBUS-FNA
have proved their value and are attractive methods, because of
their minimally invasive character [7]. But it is unclear whether a
negative result has to be double checked by a cervical mediastino-
scopy, being the gold standard in clinical staging. The goal of this
study was to assess the additional value of a mediastinoscopy after
a negative result of endosonography in patients with suspected or
proven lung cancer in our routine clinical practice. This study
shows that the NPV for endoscopic staging was 80.9%, considering
surgical staging by cervical mediastinoscopy and/or thoracotomy
as the gold standard, and 90% for a cervical mediastinoscopy. But
more importantly, we found that in every 8.8 patients 1 futile
thoracotomy could be avoided by performing an additional med-
iastinoscopy. This reduced the number of futile thoracotomies
by 50%.
Comparable studies, publishing results of both techniques, are
limited. In a recent study of patients with a high clinical suspicion
of nodal disease who underwent EBUS-TBNA followed by medias-
tinoscopy, the NNT was 3.6 patients [9]. The ASTER trial, a rando-
mized controlled trial comparing mediastinoscopy with combined
endoscopic staging followed by mediastinoscopy, demonstrated a
Table 2: Reliability of endosonography and cervical
mediastinoscopy in mediastinal staging
NPV NNT
All patients (n = 147)
Endosonography (n = 147)
CM gold standard 88.7% 8.8
CM and/or thoracotomy gold standard 80.9%
Cervical mediastinoscopy (n = 124)
Thoracotomy gold standard 90% 10
High probability based on FDG-PETa (n = 55)
Endosonography (n = 55)
CM golden standard 83.6% 6.1
aPatients with 18FDG-PET positive mediastinal lymph nodes.
CM: cervical mediastinoscopy; NPV: negative predictive value; NNT:
number needed to treat, to find one false-negative result of the
diagnostic procedure.





(n = 14 patients)
Positive by thoracotomy, no
cervical mediastinoscopy
(n = 4 patients)
Positive by thoracotomy, despite
cervical mediastinoscopy
(n = 10 patients)
Total FN result
endosonography
(n = 28 patients)
2 R 2 – – 2
2 L 2 – – 2
4 R 7 1 4 12
4 L 5 – 1 6
5 – 1 3 4
6 – – – –
7 4 1 2 7
8 – – 1 1
9 – 1 – 1
R: right; L: left; FN: false-negative.
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NNT of 11 patients [7]. In a prospective trial, performing both
EBUS-TBNA and mediastinoscopy under general anaesthesia in all
patients, similar results were achieved for both techniques, suggest-
ing that mediastinoscopy could be replaced by endobronchial
staging [10].
These differences in NNT may be explained by patient selection
and performance of either technique. It is, therefore, important to
determine factors that may identify patients who beneﬁt most from
an additional mediastinoscopy after negative endosonopraphy.
First, the probability of mediastinal metastases. Based on the
criteria of the European Society of Thoracic Surgeons [2], all
patients in our study had an elevated risk of mediastinal metasta-
ses, necessitating invasive staging. In a subanalysis of the ASTER
trial, according to the risk of mediastinal metastases, no additional
value of a mediastinoscopy was demonstrated in patients with a
normal mediastinum based on CT and PET imaging, since the
pretest probability was already low. However, in patients with an
abnormal mediastinum, a number of 7 patients who needed an
additional mediastinoscopy to avoid one futile thoracotomy was
found [11]. In our study, the prevalence of mediastinal metastases,
after a negative result of endosonography, was still 19% and
overall we found a NNT of 8.8 patients, to make an additional
mediastinoscopy valuable. Yet, in patients with an abnormal
mediastinum, thus by excluding patients with only a centrally
located tumour or clinical suspicion because of only hilar lymph
nodes, this number dropped to 6.1 patients.
Secondly, the completeness of endoscopic staging. Combined
endosonography has the advantage that nearly all mediastinal
lymph node stations are accessible and the diagnostic yield of the
combination of EUS-FNA and EBUS-TBNA is probably higher than
that of either technique alone [12]. Nevertheless, in our study,
both endoscopic modalities were used in only 20% of patients
and the mean number of aspirated mediastinal lymph nodes was
1.5. In contrast to a complete mediastinal investigation, in daily
practice performance of endosonography seems to be guided by
suspicion on imaging, with regard to both the technique and sub-
sequent aspiration of lymph nodes, and should therefore be clas-
siﬁed as selective sampling [13]. For mediastinoscopy, minimal
requirements to ensure a high NPV have been deﬁned [2]. Yet, the
yield is dependent on the experience of the surgeon and the thor-
oughness of the mediastinal assessment, as illustrated when more
extensive surgical procedures are performed, which demonstrate
an even higher NPV [14, 15].
However, these procedures are not widely used. In this series
on average four mediastinal lymph node stations were biopsied.
When a comparable examination of the mediastinum is per-
formed by endosonography, equivalent reliability may be
achieved [10, 16]. However, performance of endosonography is
not only dependent on the operator, but also strongly inﬂuenced
by the condition, and, in particular, comfort of the patient. From
this aspect, performance under general anaesthesia creates ideal
conditions for endosonography, in contrast to conscious sedation,
allowing a more complete examination of the mediastinum, but
diminishes one of the advantages of endosonography in an
outdoor clinical setting. Furthermore, in our study the false-
negative result of endosonography is not only explained by an
incomplete examination, since in 7 patients, lymph nodes also
aspirated during endosonography appeared positive by mediasti-
noscopy and in another 6 patients by thoracotomy.
Thus, thirdly, representativeness of the yield of endosonography
is an important aspect in determining the need for a mediastino-
scopy. A representative sample is supposed to contain lympho-
cytes in various stages of differentiation, and is a prerequisite for a
reliable procedure [17], but also when this criterion was met, we
found metastases in aspirated lymph node stations in 9 of 28
patients with a false-negative endosonography. This indicates a
sampling error, probably as a result of aspiration of a negative
lymph node in an otherwise positive lymph node station, or
even negative lymphoid tissue in a positive lymph node due to
micrometastases. Furthermore, also by pathological assessment
micrometastases may be missed in a representative aspirate. The
same is possible for a mediastinoscopy, but less likely, since the
yield of a mediastinoscopy in terms of the amount of tissue, if
well performed, is huge in comparison with the yield of endoso-
nography and pathological assessment is based on histology
instead of cytology. For instance, the chance to detect isolated
tumour cells in, or micrometastases near the marginal sinus of
a lymph node, is higher in a histological biopsy than in a FNA
specimen.
Finally, in assessing the need for an additional mediastinoscopy,
the consequence of minimal mediastinal disease is another con-
sideration. Since patients with mediastinal lymph node involvement
form a heterogeneous group, using endosonography to rule out
multilevel or bulky N2 disease and accept the possibility of minimal
residual disease only found by thoracotomy may be an option.
Surgical treatment, then followed by adjuvant chemo- and radio-
therapy in case of unexpected minimal N2 disease, can be an alter-
native to induction- or even deﬁnitive chemo-radiotherapy for
these patients with minimal mediastinal involvement.
The retrospective nature of this study is a limitation when com-
paring the potential reliability of endosonography and mediastino-
scopy in mediastinal nodal staging, but makes it possible to compare
the performance of those two techniques in daily practice.
Considering additional diagnostic procedures in the workup of
patients with lung cancer, the burden for the patient should be
balanced against the beneﬁt, and therefore, local expertise in and
Table 4: False-negative mediastinal endosonography: analysis of yield of endosonography, n = 28 patients
Detected by cervical mediastinoscopy
(n = 14 patients)
Detected by thoracotomy
(n = 14 patients)
Total
Metastasis in: aspirated LN station and representative 6 3 9
Metastasis in: aspirated LN station, not representative 1 3 4
Metastasis in: non-aspirated LN station 5 6 11
No LN station aspirated 2 2 4
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performance of each technique are important aspects to take into
account.
In conclusion, in patients with non-small-cell lung cancer and
an indication for mediastinal staging, performing a cervical med-
iastinoscopy after a negative result of endosonography reduced
the number of futile thoracotomies by 50%. Overall, on average
8.8 patients had to undergo an additional mediastinoscopy to ﬁnd
one false-negative result of endosonography, but when only
patients with suspicious mediastinal lymph nodes on FDG-PET are
taken into account, this NNT diminished to 6.1 patients.
Thus, in patients with a high probability of mediastinal metasta-
ses, a cervical mediastinoscopy should not be omitted after a
negative result of endosonography, not even when the aspirate
seems representative, based on the presence of an adequate
number and maturation of lymphocytes.
Conﬂict of interest: none declared.
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